Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

United Therapeutics (UTHR) Non Operating Income (2016 - 2025)

Historic Non Operating Income for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $49.5 million.

  • United Therapeutics' Non Operating Income rose 879.12% to $49.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.9 million, marking a year-over-year increase of 908.52%. This contributed to the annual value of $162.0 million for FY2024, which is 8120.81% up from last year.
  • Latest data reveals that United Therapeutics reported Non Operating Income of $49.5 million as of Q3 2025, which was up 879.12% from $43.9 million recorded in Q2 2025.
  • In the past 5 years, United Therapeutics' Non Operating Income registered a high of $97.3 million during Q1 2021, and its lowest value of -$51.8 million during Q2 2022.
  • Its 5-year average for Non Operating Income is $19.4 million, with a median of $24.8 million in 2023.
  • The largest annual percentage gain for United Therapeutics' Non Operating Income in the last 5 years was 101839.08% (2021), contrasted with its biggest fall of 105714.29% (2021).
  • Quarter analysis of 5 years shows United Therapeutics' Non Operating Income stood at -$28.8 million in 2021, then surged by 81.6% to -$5.3 million in 2022, then soared by 766.04% to $35.3 million in 2023, then increased by 9.92% to $38.8 million in 2024, then grew by 27.58% to $49.5 million in 2025.
  • Its Non Operating Income was $49.5 million in Q3 2025, compared to $43.9 million in Q2 2025 and $40.7 million in Q1 2025.